James M. Hughes, Ph.D.

Jim Hughes develops strategic legal arguments, drafts and argues motions, and litigates cases involving securities fraud.


Jim has also represented industrial workers exposed to silica and asbestos in the workplace, arguing before appellate courts in Illinois and Minnesota on behalf of occupational disease victims. He has shared his experience with silica litigation and product identification at several national conferences, addressing the plaintiff's perspective and other pertinent issues.

A published author on several legal and academic themes, Jim’s law review article, “Informing South Carolina Capital Juries About Parole” (44 S.C. Law Review 383, 1993) was cited in 2000 by U.S. Supreme Court Justice John Paul Stevens in his dissenting opinion in Ramdass v. Angelone. His reported opinions include Ison v. E.I. DuPont de Nemours & Co. (Del. 1999), In re Minnesota Asbestos Litigation (Minn., 1996), W.R. Grace & Co. v. CSR Ltd., (Ill. App. Ct. 1996) and In re Tutu Wells Contamination Litigation (D.V.I. 1995). 

A former professor of philosophy, Jim began his legal career with the plaintiffs' bar after clerkships with the South Carolina Office of Appellate Defense and a business, employment and intellectual property defense firm. He is recognized as an AV® rated attorney by Martindale-Hubbell®.

Open Bio


  • J.D., University of South Carolina School of Law, 1993
  • Ph.D., University of Illinois, Chicago, 1983
  • M.A., University of Illinois, Chicago, 1976
  • B.A., University of Minnesota, 1975


  • American Association for Justice
  • South Carolina Association for Justice

Licensed In

  • South Carolina

Admitted to Practice Before

  • U.S. Supreme Court
  • U.S. Court of Appeals for the First, Second, Fourth, Fifth, Eighth, and Eleventh Circuits
  • U.S. District Court for the District of South Carolina

Awards and Accolades

  • Lawdragon

    2019 Lawdragon 500 Leading Plaintiff Financial Lawyers


Active Case

Corporate Takeover Litigation

When directors and officers of a public company decide to undertake a corporate transaction such as a merger, acquisition or leveraged buyout, we work with company shareholders to help maximize share value and to avoid conflicts of interest and corporate waste, providing them with the information needed to cast an informed vote.

More Information


William H. Narwold

Off-Label Marketing: Medtronic Inc.

By allegedly engaging in a pervasive campaign of off-label marketing, advising doctors to use its Infuse® Bone Graft in ways not approved by the FDA, this securities fraud case addressed Medtronic’s sudden stock price drop after investors learned of the FDA and DOJ investigation into this practice.

More Information